ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN SECOND COMPLETE REMISSION—Similar Outcomes After Matched Related and Unrelated Donor Transplant: A Study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon)

REFERENCES

• Moghrabi A, Levy D E, Asselin B L, et al. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukaemia. Blood 2007; 109: 896–904
   PubMed Web of Science ®Google Scholar
• Goubin A, Auclerc F M, Auvrignon A, et al. Survival in France after childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma. Eur J Cancer 2006; 42: 534–541
   PubMedGoogle Scholar
• Pui C H, Sandlund J T, Pei D, et al. Improved outcome for children with acute lymphoblastic leucemia: results of Total Therapy Study XIIIB at St. Jude Childrens Research Hospital. Blood 2004; 104: 2690–2696
   PubMed Web of Science ®Google Scholar
• Badell I, Cubells J. Therapeutic results in childhood acute lymphoblastic leukaemia with the SHOP protocols of the Spanish Society of Pediatric Hematology and the Spanish Society of Pediatric Oncology, 1989–2005. Rev Esp Pediatr. 2005; 61: 273–281
   Google Scholar
• Gaynon P S. Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol. 2005; 131: 579–589
   PubMed Web of Science ®Google Scholar
• Hahn T, Wall D, Camitta B, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukaemia in children: an evidence-based review. Biol Blood Marrow Transplant 2005; 11: 823–861
   PubMed Web of Science ®Google Scholar
• Badell I, Muñoz A, Ortega J J, et al. Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983–1998. Bone Marrow Transplant 2005; 35: 895–901
   PubMedGoogle Scholar
• Veys P, Amrolla P, Rao K. The role of haploidentical stem cell transplantation in the management of children with haematological disorders. Br J Haematol. 2003; 123: 193–206
   PubMed Web of Science ®Google Scholar
• Flomenberg N, Baxter-Lowe L A, Confer D, et al. Impact of HLA class I and HLA class II high resolution matching on outcomes of unrelated bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004; 104: 1923–1930
   PubMed Web of Science ®Google Scholar
• Oakhill A, Pamphilon D H, Potter M N, et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol. 1996; 94: 574–578
   PubMed Web of Science ®Google Scholar
• Green A, Clarke E, Hunt L, et al. Children with acute lymphoblastic leukaemia whom receive T-cell depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall trasplant outcome. Blood 1999; 94: 2236–2246
   PubMed Web of Science ®Google Scholar
• Bunin N, Carston M, Wall D, et al. Unrelated marrow transplantation for children with acute lymphoblastic leukaemia in second remission. Blood 2002; 99: 3151–3157
   PubMedGoogle Scholar
• Woolfrey A E, Anasseti C, Storer B, et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukaemia in children. Blood 2002; 2002–2008
   PubMedGoogle Scholar
• Dini G, Valchessi M G, Micalizzi C, et al. Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission. Bone Marrow Transplant 2003; 32: 325–331
   PubMedGoogle Scholar
• Lang P, Handgretinger R, Niethammer D, et al. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukaemia. Blood 2003; 101: 1630–1633
   PubMed Web of Science ®Google Scholar
• Afify Z, Hunt L, Green A, Guttridge M, Cornish J, Oakhill A. Factors affecting the outcome of stem cell transplantation from unrelated donors for childhood acute lymphoblastic leukaemia in third remission. Bone Marrow Transplant 2005; 35: 1041–1047
   PubMedGoogle Scholar
• Hongens S, Krance R A, Bowman L C, et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukemia. Lancet 1997; 350: 767–771
   PubMedGoogle Scholar
• Lausen B F, Heiman C, Vindelov L, Jacobsen N. Outcome of acute lymphoblastic leukaemia in Danish children after allogeneic bone marrow transplantation: superior survival following transplantation with matched unrelated donor grafts. Bone Marrow Trasplant 1998; 22: 325–330
   PubMedGoogle Scholar
• Al-Kasim F A, Thornley I, Rolland M, et al. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplant. Br J Haematol. 2002; 116: 483–490
   PubMed Web of Science ®Google Scholar
• Ortega J J, Ribera J M, Oriol A, et al. Early and delayed consolidation chemotherapy significantly improves the out of children with intermediate risk outcome of children with intermediate risk acute lymphoblastic leukaemia. Final Results of the prospective randomized PETHEMA ALL TRIAL. Haematologica 2001; 86: 586–595
   PubMedGoogle Scholar
• Cox D R. Regression models and life tables. J R Stat Soc B. 1972; 34: 187–220
   Google Scholar
• Saarinen-Pihkala U M, Gustafsson G, Rindgen O, et al. No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission. J Clin Oncol. 2001; 19: 3406–3414
   PubMedGoogle Scholar
• Sedlácek P, Formánkova R, Keslová P, et al. Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin. Bone Marrow Transplant 2006; 38: 745–750
   PubMedGoogle Scholar
• Arcese W, Guglielmi C, Iori A P, Screnci M, Carmini D, Testi A M. Umbilical cord blood transplants from unrelated HLA-mismatched donors in children with high-risk leukaemia. Bone Marrow Transplant 1999; 23: 549–554
   PubMedGoogle Scholar
• Boulad F, Steinherz P, Reyes B, Heller G, Gillio A P, Small T N, et al. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukaemia in second complete remission: a single–institution study. J Clin Oncol. 1999; 17: 197–207
   PubMedGoogle Scholar
• Gaynon P S, Harris R E, Altman A J, et al. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukaemia and an initial bone marrow relapse within12 months of the completion of primary therapy: Childrens Oncology Group study CCG-1941. J Clin Oncol. 2006; 24: 3150–3156
   PubMed Web of Science ®Google Scholar
• Zecca M, Pession A, Messina C, et al. Total body irradiation, thiotepa and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings. J Clin Oncol. 1999; 17: 1839–1846
   Google Scholar
• Borgmann A, Baumgarten E, Schmidt H, et al. Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukaemia in third remission: a conceivable alternative?. Bone Marrow Transplant 1997; 20: 939–944
   PubMedGoogle Scholar
• Gustafsson Jerberg A, Ringden O, Wianirski J. Graft-versus-leukaemia effect in children: chronic GvHD has a significant impact on relapse and survival. Bone Marrow Transplant 2003; 31: 175–181
   PubMedGoogle Scholar
• Jamieson CHM, Amylon M D, Wong R M, Blume K G. Allogeneic hemopoietic cell transplantation for patients with high-risk acute lymphoblastic leukaemia in first or second remission using fractionated total-body irradiation and high-dose etoposide: a 15-years experience. Exp Hematol. 2003; 31: 981–986
   PubMedGoogle Scholar
• Balduzzi A, Gooley T, Anasseti C, et al. Unrelated donor marrow transplantation in children. Blood 1995; 86: 3247–3256
   PubMed Web of Science ®Google Scholar
• Davies S M, Wagner J E, Shu X O, et al. Unrelated donor transplantation for children with acute leukaemia. J Clin Oncol. 1997; 15: 557–565
   PubMed Web of Science ®Google Scholar
• Borgmann A, Baldy C, von Stalkelberger A, et al. Unrelated donor stem-cell transplantation compared with chemotherapy for children with acute lymphoblastic leukaemia in second d remission: a matched pair analysis. Blood 2003; 17: 635–650
   Google Scholar
• Benito A I, Gonzalez-Vicent M, Garcia F, et al. Allogeneic peripheral blood stem cell transplantation from HLA-identical sibling donors in children with hematologic diseases: a single center pilot study. Bone Marrow Transplant 2001; 28: 537–543
   PubMedGoogle Scholar
• Meisel R, Enczmann J, Balzer S, et al. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematological malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Klin Padiatr. 2005; 217: 135–141
   PubMedGoogle Scholar
• Vicent M G, Madero L, Ortega J J, et al. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukaemia. Bone Marrow Transplant 2002; 30: 9–13
   PubMedGoogle Scholar
• Eapen M, Horowitz M M, Klein J P, et al. Higher mortality after allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents: The Histocompatibility and Alternate Stem Cell Source Working Party Committee of the International Bone Marrow Transplant Registry. J Clin Oncol. 2004; 22: 4872–4880
   PubMed Web of Science ®Google Scholar
• Mullighan C G, Bardy P G. New directions in the genomics of allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 127–144
   PubMedGoogle Scholar
• Baron C, Somogyi R, Greller R D, et al. Predictor of graft-versus-host disease in humans by donor gene-expression profiling. PLoS Med. 2007; 4: e23
   PubMed Web of Science ®Google Scholar
• Perez-Simon J A, Sanchez-Abarca I, Diez-Campelo M, Caballero D, San Miguel J. Chronic graft-versus-host disease: pathogenesis and clinical management. Drugs 2006; 66: 1041–1057
   PubMed Web of Science ®Google Scholar
• Sramkova L, Muzikova K, Froncova E, et al. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukaemia. Pediatr Blood Cancer 2007; 93–100
   PubMedGoogle Scholar